Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Bonus Apr 05, 2010 Apr 06, 2010 Feb 25, 2010 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 30, 2006 Aug 31, 2006 Apr 28, 2006 Bonus Ratio: 1 share(s) for every 1 shares held Zydus ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain ...

Zydus Lifesciences Chairman Pankaj R Patel has been awarded the prestigious Padma Bhushan for his contributions to the ...

Zydus Lifesciences Chairman Pankaj R Patel awarded Padma Bhushan for contributions to healthcare innovation. Patel emphasizes ...

Pankaj R Patel, Chairman of Zydus Lifesciences, has been awarded the Padma Bhushan for his contributions to India's ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

Innovation from India will bring critical access to affordable healthcare and empower people to lead healthier and more ...

Oxfam International’s report highlights how colonial wealth extraction, particularly from India, has laid the foundation for modern economic inequalities, including the dominance of unearned ...